EVALUATION OF IN-VITRO ANTIFUNGAL POTENTIALITIES AND GC/MS SPECTROSCOPIC APPROACH OF CLEISTANTHUS COLLINUS (ROXB.) BENTH. EX. HOOK. F.
HTML Full TextEVALUATION OF IN-VITRO ANTIFUNGAL POTENTIALITIES AND GC/MS SPECTROSCOPIC APPROACH OF CLEISTANTHUS COLLINUS (ROXB.) BENTH. EX. HOOK. F.
Prathamanjali Satapathy, Vijaya Taratte * and Y. T. Rajesh Babu
Sri Venkateswara University College of Sciences, Sri Venkateswara University, Tirupati, Andhra Pradesh, India.
ABSTRACT: India is the home to the familiar plant Cleistanthus collinus (Roxb.) Benth. ex Hook. F (Euphorbiaceae) has great ethnomedicinal and therapeutic applications. The present study was designed to assess the phytochemical profile and investigate the antifungal effectiveness of leaf, bark and fruit extracts by using the agar well diffusion method. All crude extracts from leaf, bark, fruit and fractions derived also demonstrated significant antifungal activity (20-80%), but the methanol extracts showed a remarkable antifungal spectrum; as a result, GC-MS analysis was performed on it. From this GC-MS analysis, 14 chemicals, including alkanes, glycosides, phenols, flavonoids and steroids were identified, while leaf methanol extract has high phytochemical diversity with 9 compounds than bark with 6 compounds and fruit with 5 compounds. 1, 2, 3-Benzenetriol, 3-O-Methyl-d-glucose and Undecane are a few significant molecules with larger area percentages that demonstrated biological value. These compounds have been linked to anti-cancer, anti-inflammatory, anti-microbial and antioxidant properties. The current results collectively highlight the appreciable antimicrobial potential of C. collinus and its numerous chemical compounds that are physiologically active and offer a thorough understanding of the phytochemical profile, which could be exploited to create plant-based medications.
Keywords: Agar well-diffusion method, Antifungal activity, Cleistanthus collinus, GC-MS, Phytochemical profile
INTRODUCTION: Rising antibiotic resistance has emerged as a serious hazard to human well-being worldwide 1. The rising prevalence of drug-resistant diseases necessitates identifying and isolating novel bioactive components from medicinal plant species utilizing standardized contemporary scientific techniques. Medicinal compounds obtained from plants might provide innovative and accessible techniques to pathogenic organisms.
According to the World Health Organisation (WHO), conventional drugs produced from plants with medicinal properties continue to assist 80% of poor countries. WHO has also documented a list of over 20,000 therapeutic plant species and identified these plants as a possible driver of new medications 2.
The antibiotic era, which has lasted barely 80 years, has recently entered a time of gradual and extensive appearance of drug-resist microbes, threatening to end this era. Microbial diseases, especially fungus, have quick reproductive rates, malleable genes, and the capacity to adapt to environmental conditions containing a high concentration of possible hazardous substances that apply significant selective stresses.
Fungi's eukaryotic chemistry makes them particularly dangerous infections due to a smaller range of selective therapeutic targets over which inhibitors not hazardous to human, animal, and plant hosts may be created. Moreover, there do not exist medicinal vaccination or supplementary immune-mediated therapies present to assist people in their health care, necessitating dependence on a restricted arsenal of antifungal medication classes to combat an increasing wave of fungal diseases 3. The worldwide stress of fungus-related infections is escalating. Over 150 million severe instances concerning fungal illnesses occur each year worldwide, leading to nearly 1.7 million fatalities. The aforementioned numbers are rapidly increasing, owing to a variety of societal and medical advances in recent decades that have aided the proliferation of fungal diseases 4. To settle this problem, novel antifungal drugs are required and plants are the main wellsprings of novel drugs.
Due to their vast and varied organic components, which may have an important physiological influence on the human body, medicinal plants have been used to treat human ailments for centuries. Natural assets, such as plants with medicinal properties, which possess a wide range of phytocompounds potential as traditional medicine for treating chronic and infectious illnesses, have long been seen as safer and more efficient options with fewer adverse effects than synthetic drugs 5. Owing due to their diverse pharmaceutical qualities, plants high in bioactive phytomedicine components such as alkaloids, flavonoids, tannins, and polyphenols have been utilised to treat diseases 6.
Around 25% of the active ingredients of medicinal plants that have been used as legal drugs have been discovered 7. Cleistanthus collinus is an essential medicinal tree that has piqued the interest of researchers owing to its potential for medication development. C. collinus, a member of the Euphorbiaceae family, is a small tree featuring ellipse foliage and its silken villous spike. It tends to occur in South Indian deciduous dry highland forests, Sri Lanka and Malaysia 8. Cleistanthus A and Cleistanthus B, diphyllin glycosides, are cytotoxic to a variety of cancerous cell lines 9. Because of its unique pharmacological active principles, the isolation of independent bioactive chemicals of C. collinus might be widely exploited in the pharmaceutical industry. Despite being a toxic plant, its active constituents have been investigated for medicinal qualities such as antihypertensive, diuretic, and anticancer properties. Active compounds in C. collinus that show ability will have a good probability of being developed into drug use 10. The plant's stem bark can be used as an antiseptic in skin illnesses and to treat bovine hoof sores 11. A detailed examination of the literature reveals that two have been discovered in the assay of anti-bacterial activity reports 12, 13 and one in antifungal activity 14 from this plant. The primary goal of this study was to appraise the GC-MS analysis study and examine the antifungal potentiality of diverse plant solvent extracts.
MATERIALS AND METHODS:
Sample Collection: The plant C. collinus was handpicked from the vicinity of Gopavaram village, Andhra Pradesh, India (17˚22’09.16” N 81˚47’48.42” E), in January 2022 and authenticated by Prof. N. Savithramma, Sri Venkateswara University, Botany Department, Tirupati, Andhra Pradesh, India, with accession number SVUH: 1226.
Extraction of Plant Material: Plant parts were harvested, dried in the shade at 32oC and ground into a fine powder. The powder was then sieved through a 0.5 mm sieve to maintain consistent molecule size and stored in sterile containers until usage. For the extractions of leaves, bark and fruit, the following solvents were selected: methanol, ethyl acetate and chloroform in the ascending order of polarity. Using a soxhlet extractor, the phytochemicals from the plant material were isolated using the aforementioned solvents, which were then stored for 72 hours in sealed jars. A thick concentration was generated when the extracts were collected in a rotary evaporator at 45°C under reduced pressure. The crude extracts were kept in a 4°C refrigerator for future usage.
Collection of Test Pathogens: Four test fungal species; two non-filamentous human pathogens Saccharomyces cerevisiae (MTCC 4742), Candida albicans (MTCC 227) and two filamentous plant pathogens Aspergillus niger (MTCC 282) and Aspergillus flavus (MTCC 277) were utilized in this work; they were acquired from the Microbial Type Culture Collection (MTCC), IMTECH, Chandigarh, India.
Preparation of Test Sample: The methanol, ethyl acetate and chloroform extracts were dissolved in 10% aqueous DMSO (Himedia) to get different concentrations (10 mg, 5 mg and 2.5 mg per 20μL). 10% aqueous DMSO was utilized as the negative control (solvent control). As positive reference standards, Fluconazole (Central Drug House P. Ltd., India) was employed for fungal strains at a dosage of 30μg/mL.
Antifungal Activity Assay: The agar well diffusion method was used to assess the antifungal potentialities of plant extracts in a Potato Dextrose Agar (PDA) medium. A sterilized L-shaped bent rod was used to disperse the 100 μL fungal inoculums evenly and allowed it to harden in the Petri plates.
With the aid of a sterile cork borer, 5mm-diameter wells were made on the plates and filled with various solvent extracts (10 mg, 5 mg and 2.5 mg per 20μL in 10% aqueous DMSO) positive and negative controls of 20 µL each.
After a 48-hour incubation period at 26°C, the inhibitory zone's diameter was determined. The usual positive and negative controls were fluconazole 30 μg/mL and DMSO (10%) and the results of each test were averaged after being repeated three times. A strict aseptic environment was maintained during the entire microbiological experiment.
GC-MS Analysis: The extracts were examined using the Agilent Technologies GC-MS (GC-8890, GC/MS 5977 MSD). With an 18 mL/min split flow and a 3 mL/min purge flow in the injection mode. The temperature of the oven was programmed to range from 75°C to a maximum of 360°C.
The column was a Polar Columns (DB-WAX) & HP-5 MS UI with a 1.21 mL/min flow rate and helium gas (99.99%) as the carrier gas. A temperature range of 60°C to 325oC was set for the column. The GC-MS lasts for a total of 53.5 minutes. The sample pieces were ionized using the EI mode (70 eV). The spectra of the unknown components were compared to the spectrum of the known components using the Spectral Library and Database (licensed NIST 2017 Library; Software: Open Lab CDS 2.5 version).
RESULTS AND DISCUSSION:
Anti-fungal Activity: The antifungal bioassay findings against pathogens using crude extracts of the C. collinus plant (10 mg, 5 mg, and 2.5 mg of each) were described regarding the zone of inhibition's diameter. According to the observed inhibitory zones, which were also correlated with their tested doses, the entire extract and various fractions of C. collinus displayed strong antifungal activity against C. albicans, considerable anti-yeast ability against S. cerevisiae and moderate activity against A. flavus and A. niger Table 1.
The majority of the studied substances had strong inhibitory effects on C. albicans, among them fruit methanol crude extract showing the highest activity (25mm), followed by leaf methanol extract (21mm), bark ethyl acetate (19mm) and bark methanol (17.3mm). Methanol and ethyl acetate extracts showed high to moderate activity against test fungal pathogens while chloroform extracts had the lowest activity.
Here, A. flavus shows the strongest resistance to crude extracts of C. collinus, whereas C. albicans is the most vulnerable. It was discovered that the fractions containing the highest secondary metabolites concentration had higher levels of antifungal activity.
Moreover, the highest inhibitory properties against A. flavus were exhibited by the fruit methanol extract (12.3mm) followed by bark ethyl acetate (10.3mm) and bark methanol (10mm) extracts.
Whereas both ethylacetate and chloroform extracts of leaf and fruit did not show any activity. Contrary to A. flavus, A. niger was more susceptible to bark methanol extract (14mm) followed by fruit methanol extract (11.3mm).
The effectiveness of fluconazole has consistently outperformed that of plant solvent extracts, which has made it a recognized measure for comparing their effects. The DMSO containing well (negative control) exhibited no bioactivity.
TABLE 1: ANTIFUNGAL ACTIVITY OF DIFFERENT EXTRACTS (ME, EA &CH) AT THE DOSAGES OF 10mg, 5mg, AND 2.5mg
Plant part | Extract | S. cerevisiae | C. albicans | A. flavus | A. niger | ||||||||
10mg | 5mg | 2.5mg | 10mg | 5mg | 2.5mg | 10mg | 5mg | 2.5mg | 10mg | 5mg | 2.5mg | ||
Leaf | ME | 8.6±
0.5 |
8±0 | 8±1 | 21±1 | 13.6±0.5 | 12±1 | 6.6±.0.57 | 6±0 | - | 7.6±
0.57 |
6.5±0.7 | - |
EA | 8±1 | - | - | 15±1 | 12±1 | 10.3±0.5 | - | - | - | - | - | - | |
CH | 10±1 | - | - | 17±1 | 13±1 | 8±0 | - | - | - | - | - | - | |
Bark | ME | 13±1 | 9 ±1 | 8±1 | 17.3±0.5 | 15±1 | 11.6±0.5 | 10±1 | 8±1 | 6.6±.0.57 | 14.3±0.57 | 12±1 | 9±1 |
EA | 8.3±0.5 | 7.3±
0.5 |
- | 19.3±0.5 | 14±1 | 10±1 | 10.3±.0.57 | 9.6±.0.57 | 7.6±.0.57 | 9±1 | 7.6±0.57 | 6.3±0.57 | |
CH | 7.6±
0.5 |
7.6±0.5
|
- | 11±1 | 9±1 | 8±1 | - | - | - | - | - | - | |
Fruit | ME | 10.6±
0.5 |
7.6±0.5 | 7.6±0.5 | 25±1 | 22±1 | 21±1 | 12.3 ±.0.57 | 10±1 | 6±0 | 11.3±0.57 | 10±1 | 7±1 |
EA | 8±1 | 7±0 | - | 13±1 | 11.3±0.5 | 8±0 | - | - | - | - | - | - | |
CH | 11±1 | 8.6±0.5 | 7.6±0.5 | 16±1 | 12±1 | 8.6±0.5 | - | - | - | - | - | - |
Values represent mean ± standard deviations; ME stands for methanol extract, EA for ethyl acetate, CH for chloroform, and "-" for no zone of inhibition. A zone of inhibition with a diameter of less than 6 mm was considered inactive. Source: authors.
Furthermore, the antifungal activities of higher concentration (10mg) plant extracts were compared to the positive control fluconazole's inhibition capacity Fig. 1.
FIG 1: ANTIFUNGAL ACTIVITY (% OF INHIBITION) WITH RESPECT TO +’ VE CONTROL
The highest percentage of inhibition (86.2%) against C. albicans was found in the fruit methanol extract of C. collinus, followed by leaf methanol (72.4%) and bark ethyl acetate (65.5%). The remaining eight plant extracts, except bark chloroform extract, demonstrated more than 50% inhibitory effect against C. albicans compared to the standard. All plant extracts inhibited S. cerevisiae growth in a medium-to-high range (30-55%). S. cerevisiae and C. albicans were more susceptible and all plant extracts tested inhibited their growth, whereas A. flavus and A. niger were more resistant and only methanol extracts with moderate activity, i.e., 20-45% when compared to standard, inhibited their growth. The antifungal activity of leaf acetone, water and benzene extracts from C. collinus studied by Majiet al., 2010 against C.albicans ranged from 13 to 8 mm12 however in my study Methanol, Ethyl acetate and chloroform extracts of leaves showed higher activity ranged from 21 to 15 mm. Previous research employed aqueous and ethyl acetate solvent-based C. collinus leaf extracts against C. albicans, C. tropicalis, and C. glabrata, in which the ethyl acetate extract only showing action against C. albicans and other species being resistant 15. In addition to previous data, the current investigation demonstrates that C. collinus methanol and ethyl acetate extracts are more efficacious than the chloroform extract. This might be because the kind of solvent utilized in the extraction technique substantially influences the subsequent characterization of phytochemicals. 1,2,3 Benzenetriole has strong antimicrobial properties 25, 26 and GC-MS analysis revealed that it was found in higher concentrations in all leaf, bark, and fruit methanol extracts; this may be a reason behind the results obtained in antifungal assays. The antifungal screening supports C. collinus potentiality as a traditional cure for several fungal illnesses, including its usage as an antiseptic.
GC-MS Chemical Profiling: Methanol extracts were chosen for gas chromatography and mass spectrometry (GC-MS) analysis to examine the phytochemical composition because they displayed the highest antifungal efficacy compared to the other solvent extracts. This study demonstrates that a variety of physiologically active compounds are present in leaf, bark and fruit methanol extracts at various concentrations and also offers a thorough understanding of the phytochemical profile that may be exploited to create plant-based therapeutics. GC/MS spectrum data of the methanol extracts showed several peaks Fig. 2, 3 & 4 that indicated the presence of 14 different chemicals (9 from leaf, 6 from bark and 5 from fruit). Each of these chemicals was recognized and described using the mass fragmentation patterns and retention indices from the Spectral Library and Database (NIST 2017 Library). In Table 1, the active ingredients are listed in chronological order of retention durations, their peak area percentage, molecular formula, molecular weight, structural features and biological activities. To look at the biological effects of important substances, a review of the literature was conducted.
FIG. 2: GC-MS CHROMATOGRAM OF C. COLLINUS LEAF METHANOL EXTRACT
FIG. 3: GC-MS CHROMATOGRAM OF C. COLLINUS BARK METHANOL EXTRACT
FIG. 4: GC-MS CHROMATOGRAM OF C. COLLINUS FRUIT METHANOL EXTRACT
We discovered that most of the constituents in the C. collinus leaf methanol extract exhibit a variety of advantageous pharmacological and therapeutic activities. The leaf methanol extract provides a rich source of significant bioactive molecules. Ten different chemicals, including hydrocarbons, phenols, terpenes and glucose derivatives, were found to be present. Undecane, 1, 2, 3-Benzenetriol and 3-O-Methyl-d-glucose were discovered in all three plant sections, whereas fruit and bark extracts contained N-[3-[N-Aziridyl] propylidene] hexylamine. A little amount of the following compounds were detected only in the leaf methanol extract: 4H-Pyran-4-one, 2, 3-dihydro - 3, 5 – dihydroxy – 6 - methyl, 6-Methyl-enebicyclo [3.2.0] hept-3-en-2-one, 5-Hydroxymethylfurfural, Phenol, 5-ethenyl-2-methoxy and D-Allose. Only bark extracts included decane, 4(3H)-Pteridinone, 2-amino-7, 8-dihydro-8-methyl-6, 7-diphenyl and fruit extracts had trace amounts of phthalic acid, 5-methylhex-2-yl heptadecyl ester.
FIG 5: PICTORIAL DATA OF ANTIFUNGAL ACTIVITY OF C. COLLINUS (LEAF, BARK & FRUIT) METHANOL EXTRACTS
TABLE 2: BIOACTIVE CHEMICAL PROFILE OF C. COLLINUS THROUGH GC-MS
The chemicals found in this study were mostly stated to have anti-cancer, antibacterial, anti-virulence, anti-inflammatory, neuro-protecting, and antioxidant effects according to the reported biological activities. 1, 2, 3-Benzenetriol is a phenolic molecule that is most abundantly present in fruit extracts (63.09%), leaf extracts (35.95%) and bark extracts (5.1%). It is an effective anti-microbial and antiviral agent and leads to the death of cancer cells by apoptosis. The highest concentration of 3-O-Methyl-d-Glucose, a glucose derivative with good anti-cancer capabilities, was identified in the bark extract (67.88), followed by the leaf (25.33) and the fruit extract (4.03). Undecane is a hydrocarbon compound that is present in fruit and bark extracts in low amounts and high concentrations in bark extract (7.42).
It possesses anti-inflammatory and antioxidant activities. Decane contains co-carcinogenic and tumor-promoting properties but is reported only in bark extract. 2-Oxo-5-phenyl-4-(4-methoxyphenyl)-1, 2-dihydro-5H-indeno [1, 2-d] pyrimidine reported in leaf extract in high concentration (27.54), although its bioactivities have not been studied. Earlier work by Pratheepa M. et al., 2012 revealed the GC-MS analysis of the plant leaf acetone extract which showed 8 different bioactive compounds from which the novel chemical dioctyl phthalate observed at a peak area of 95.23% which may operate as a very promising medicinal agent for persons suffering from cancer or afflicted with fatal diseases, etc 16. Arulmanickam P. and Chitra T. et al., 2020 studied leaf powder ethanolic extract and revealed 13 different types of bioactive compounds, but only six of them can carry out specific biological functions. These include alpha-methyl mannofuranoside (36.25%) for its antibacterial and antifungal activity, undecanoic acid (1.88%) for its cytotoxic, anticancer, and anti-microbe properties, 5-O-methyl-D-gluconic acid dimethylamide (4.86%) for its antioxidant and anti-microbial properties, Cyclopropanetetradecanoic acid, 2-Octyl-, Methyl ester (3.20) for its anti-microbial activity and Pentanoic acid, 2 (Aminooxy) (3.59%) for its Anti-oxidant and lubricantproperties 17.
Suman et al., 2013 found four bioactive compounds in the leaf's aqueous, hot extracts, with 4-OMethylmannose (70.12%) having antibacterial activity and 1,2,3-Benzenetriol (21.76%) having antioxidant, antibacterial, antiseptic, fungicide, antimutagenic, antidermatitic, pesticide, dye and candidicide properties. In contrast, the methanol extract contained significant amounts of thiophene (antimicrobial action), tetrahydro-2-methyl-myo-inositol (48.54%), 1,2,3-benzenetriol (7.51%) and Vitamin E (d -α-tocopherol) (6.52%). Higher concentrations of 4-O-methylmannose (Secondary messenger) and 5-Methyl-2-trimethylsilyloxy-aceto phenone (7.35%) were found in the ethanol extract. In the ethyl acetate extract, there were 15 compounds detected, the main ones being silane (Coupling Agent) and trimethyl [5-methyl-2-(1-methyl ethyl) phenoxy] anthracene (7.06%) 9. Parasuraman et al., 2009 reported 17 compounds, of which 14 are from fresh leaves and 5 are from dry leaves. 3-Omethyl-d-glucose (32.88%), Benzenetriol (22.43%), 1.6- Anhydro - â - Dglucopyranose (15.66%), Heptacosane (8.99%), 2-Hydroxy-7methoxy-4,5 diphenyl-5 Hindeno [1.2-d] pyrimidine (7.45%) and Eicosane (3.76%) were found in fresh leaves, whereas 3-O-methyl-d-glucose (41.61%), Benzenetriol (Pyrogallic acid, Pyrogallol) (25.06%), n- Hexadecanoic acid (10.60%), Heptacosane (4.41%) and 1,2-Benzenedicarboxylic acid, diisooctyl ester (3.54%) were present in dried leaves aqueous extracts 18. Kazi M. and Gude A. et al., 2022 summarized the phytoconstituents and discussed 46 compounds and their biological properties 19. Only 1,2,3-Benzenetriole (35.95) and 3-O-methyl-d-glucose (25.33) were previously reported of the 9 compounds we found in leaf methanol extract; the other compounds were discovered for the first time. To the best of my knowledge, no studies on the GC-MS analysis of methanol extracts of C. collinus fruit and bark have been published yet. In contrast to earlier findings, we present the most recent analysis of the GC-MS profile of the methanolic extracts of leaves, bark and fruits in our investigations.
CONCLUSION: These findings have established a solid scientific foundation for the use of the plant Cleistanthus collinus in traditional medicine to treat fungal infections. Compared to chloroform extracts, methanol and ethyl acetate extracts showed high antifungal activity. In particular, C. albicans and S. cerevisiae, which displayed the strongest antifungal activity, excelled over other fungal strains examined. GC-MS study revealed 15 phytochemical components with antifungal, antibacterial, antioxidant, anti-inflammatory and anti-cancer properties. As far as I am aware, very little work has been done on the antifungal activity of C. collinus, as there is very little literature accessible on the antifungal activity of this plant species. We believe that more studies in this area will aid in developing novel antifungal and anticancer drugs.
ACKNOWLEDGMENT: The Department of Botany at Sri Venkateswara University provided the facilities and equipment for our research and also thankful to Prof. N. Savithramma, Department of Botany, Sri Venkateswara University, for helping in the identification of the plant. Dr. Ummidi Ravi Shankar of the Mic gene laboratory in Visakhapatnam is acknowledged by the first author for his assistance during various stages of this research.
Author Contributions: S. Prathamanjali assisted and conducted the experiment, calculations, and literature analysis and prepared the manuscript. Prof. T. Vijaya guided the co-authors and prepared the final version of the manuscript. Y.T. Rajesh Babu helped in conducting the experiments and preparation of the manuscript. All authors read the final version of the manuscript and accepted it.
CONFLICTS OF INTEREST: The authors declare that they hold no competing interests.
REFERENCES:
- Rahul C, Kanika S and Prashant K: Biochemical and molecular mechanisms of antibiotic resistance in Salmonella spp. Research in Microbiology 2023; 174(1–2): 103985.
- Natalia V, Elisavet S, Chrysa V, Christina T and Eugenia B: Towards Advances in Medicinal Plant Antimicrobial Activity: A Review Study on Challenges and Future Perspectives. Microorganisms 2021; 9(10): 2041.
- Neil AR, Carolyn J, Judith B, Alix TC, Christina AC, David SP, Tihana B, Thomas SH, Nathan W, Mike B, Tom C and Keegan E: The importance of antimicrobial resistance in medical mycology. Nature Communications 2022; 13: 5352.
- Katharina K, Maria AB, Frank M and Didac CG: Fungal infections in humans: the silent crisis. Microbial Cell 2020; 7(6): 143–145.
- Hong Ngoc TP, Quan VV, Michael CB and Christopher JS: Phytochemicals Derived from Catharanthus roseus and Their Health Benefits. Technologies 2020; 8(4), 80.
- Murugan PK, Salim A, Chenthamara D, Robert B and Subramaniam S: Therapeutic and pharmacological efficacy of selective Indian medicinal plants – A review. Phytomedicine Plus 2021; 1(2): 100029.
- Konappa N, Arakere CU, Krishnamurthy S, Chamanalli KP and Jogaiah S: GC–MS analysis of phytoconstituents from Amomum nilgiricum and molecular docking interactions of bioactive serverogenin acetate with target proteins. Scientific Reports 2020; 10: 16438.
- Alladi M and Janjam H: Cleistanthus collinus Indian J of Critical Care Medicine 2019; 23(4): 256–259.
- Chichaghare AR, Deshmukh HK, Nasam MK and Jamatiya A: Garari (Cleistanthus collinus): Multipurpose hedge crop for organic farming through agro forestry intervention. Journal of Pharmacognosy and Phytochemistry 2019; 8(2): 2124-2127.
- Subramanian U, Chandrashekaran G and Debdatta B: Effects of Cleistanthus collinus on the reproductive system of male Wistar Rats 2022; 26(3): 460–468.
- Murthy EN, Pattanaik C, Sudhakar C and RajuVS: Piscicidal plants used by the Gond tribe of Kawal Wildlife sanctuary, Andhra Pradesh. India Journal of Traditional Knowledge 2010; 1: 97-101.
- Maji S, Dandapat P, Ojha D, Maity C, Halder SK, Das Mohapatra PK, Pathak TK, Pati BR, Samanta A and Mondal KC: In-vitro antimicrobial potentialities of different solvent extracts of ethnomedicinal plants against clinically isolated human pathogens. Journal of Phytology 2010; 2(4): 57–64.
- Suman T and Elangomathavan R: Bio-prospecting of Cleistanthus collinus and its antibacterial activity. Asian Journal of Pharmaceutical and Clinical Research 2013; 6(4): 206-209.
- Chakraborty MK and Bhattacharjee A: Some common ethno medicinal uses of various diseases in Purulia district, West Bengal. India Journal of Traditional Knowledge 2006; 5:554-558.
- Suman T, Elangomathavan R, Kasipandi M, Chakkaravarthi K, Tamilvendan D and Parimelazhagan T: Diphyllin: An effective anticandidal agent isolated from Cleistanthus collinus leaf extract. Egyptian Journal of Basic and Applied Sciences 2018; 5: 130–137.
- Pratheepa M: GC-MS and in-silico analysis of Cleistanthus collinus for its activity against cancer. Drug Discovery 2012; 1(1): 23-26.
- Arulmanickam P and Chitra T: Preliminary and Secondary Phytochemistry of the Suicidal Plant Cleistanthus collinus (Roxb.). Asian Journal of Multidisciplinary Studies 2020; 8(2): 2348-7186.
- Parasuraman S, Raveendran R and Madhavrao C: GC-MS analysis of leaf extracts of Cleistanthus collinus (Euphorbiaceae). International Journal of Pharmaceutical Sciences and Research 2009; 1(2): 284-286.
- Kazi M and Gude A: A review on poisonous, pesticidal and medicinal attributes of Cleistanthus collinus (roxb.) benth. ex hook. f.. World Journal of Pharmaceutical and Medical Research 2022; 8(4): 66-78.
- Govindarajan N, Reddy Cheekala UM, Arcot S, Sundharamoorthy S, Duraisamy R and Raju I: GC-MS Analysis of n-hexane Extract of Stem Bark of Symplocos crataegoides-Ham. ex D. Don. Pharmacognosy Journal 2016; 8(6): 520-524.
- Choi D, Kang W and Park T: Anti-Allergic and Anti-Inflammatory Effects of Undecane on Mast Cells and Keratinocytes. Molecules 2020; 25(7): 1554.
- Mujeeb F, Bajpai P and Pathak N: Phytochemical Evaluation, Antimicrobial Activity, and Determination of Bioactive Components from Leaves of Aegle marmelos. BioMed Research International 2014; Article ID 497606: 11.
- Hussein JH, Mohammed YH and Hameed IH: Study of the chemical composition of Foeniculum vulgare using Fourier transform infrared spectrophotometer and gas chromatography-mass spectroscopy. Journal of Pharmacognosy and Phytotherapy 2016; 8(3): 60-89.
- Mozafari AA, Vafaee Y and Mohammad S: Phytochemical composition and in vitro antioxidant potential of Cynodondactylon leaf and rhizome extracts as affected by drying methods and temperatures. Journal of Food Science and Technology 2018; 55(6): 2220–2229.
- Gaikwad KK, Singh S and Lee YS: Antimicrobial and improved barrier properties of natural phenolic compound-coated polymeric films for active packaging applications. Journal of Coatings Technology and Research 2019; 16(1): 147–157.
- Abirami G, Durgadevi R, Velmurugan P and Ravi AV: Gene expressing analysis indicates the role of Pyrogallol as a novel antibiofilm and antivirulence agent against Acinetobacter baumannii. Archives of Microbiology 2021; 203(1): 251–260.
- Ishihara Y, Katayama K, Sakabe M, Kitamura M, Aizawa M, Takara M and Itoh K: Antioxidant properties of rare sugar D-allose: Effects on mitochondrial reactive oxygen species production in Neuro2A cells. Journal of Bioscience and Bioengineering 2011; 112(6): 638–642.
- Tohi Y, Taoka R, Zhang X, Matsuoka Y, Yoshihara A, Ibuki E, Haba R, Akimitsu K, Izumori K, Kakehi Y and Sugimoto M: Antitumor Effects of Orally Administered Rare Sugar D-Allose in Bladder Cancer. International Journal of Molecular Sciences 2022; 23: 6771.
- Akansha AS, Yuguo L, Bachchu L, Nirbhay NY, Xiang X, Jiadi X, John L and Peter CM: CEST MRI of 3-O-Methyl-D-Glucose uptake and accumulation in brain tumors. Magnetic Resonance in Medicine 2019; 81(3): 1993–2000.
- Clough SR: Decane, Encyclopedia of Toxicology. Haley and Aldrich, Inc., Bedford, NH, USA 2005; 1(2): 1144–46.
- Jaddoa HH, Hameed IH and Mohammed GJ: Analysis of Volatile Metabolites Released by Staphylococcus aureus using gas chromatography-mass spectrometry and determination of its antifungal activity. Oriental Journal of Chemistry 2016; 32(4): 2107–2116.
- Sharma S, Saxena DC and Riar CS: Changes in the GABA and polyphenols contents of foxtail millet on germination and their relationship with in-vitro antioxidant activity. Food Chemistry 2018; 245: 863–870.
How to cite this article:
Satapathy P, Taratte V and Babu YTR: Evaluation of in-vitro antifungal potentialities and gc/ms spectroscopic approach of Cleistanthus collinus (Roxb.) Benth. Ex. Hook. F. Int J Pharm Sci & Res 2023; 14(10): 4778-87. doi: 10.13040/IJPSR.0975-8232.14(10).4778-87.
All © 2023 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
11
4778-4787
2031 KB
497
English
IJPSR
Prathamanjali Satapathy, Vijaya Taratte * and Y. T. Rajesh Babu
Sri Venkateswara University College of Sciences, Sri Venkateswara University, Tirupati, Andhra Pradesh, India.
vijayasvu@yahoo.in
06 February 2023
28 April 2023
31 May 2023
10.13040/IJPSR.0975-8232.14(10).4778-87
01 October 2023